Comments*

 
  • Neuroscience

  • Events 

    Friday, May 9, 2014 | 8:00 AM - 4:00 PM

    The Biology of Aging: Novel Drug Targets for Neurodegenerative Disease

    Speakers: Carmela R. Abraham (Boston University School of Medicine), Eric H. Baehrecke (University of Massachusetts Medical School), Nir Barzilai (Albert Einstein College of Medicine), Jerry R. Colca (Metabolic Solutions Development Company), Brendan D. Manning (Harvard School of Public Health), Beth Stevens (Harvard Medical School), D. Martin Watterson (Northwestern University Feinberg School of Medicine), Haung Yu (Columbia University), Jeffrey W. Kelly (The Scripps Research Institute), Richard I. Morimoto (Northwestern University)

    Age is the major risk factor for Alzheimer's disease, and key pathways in aging biology offer targets for novel drugs. Explore recent advances in the science of aging and innovative drug discovery for Alzheimer's and other neurodegenerative diseases.

    Monday, May 19, 2014 | 7:00 PM - 9:30 PM

    What Can Robots and Economics Teach Us About Humanity?

    Keynote Speakers: Ernst Fehr (University of Zurich), Rolf Pfeifer (University of Zurich)

    While we may think of our intelligence and ability to make choices as properties of the human brain, insights from the fields of artificial intelligence and economics paint a more complicated picture. Join two experts in the field to learn more!

    Thursday, June 26, 2014 | 7:45 AM - 5:45 PM

    Demyelination and Remyelination: From Mechanism to Therapy

    Speakers: Douglas Arnold (McGill University), Diego Cadavid (Biogen Idec), Patrizia Casaccia (Mount Sinai School of Medicine), Jonah Chan (University of California, San Francisco), Andrew Eisen (Acorda Therapeutics), Charles ffrench-Constant (MRC Centre for Regenerative Medicine, University of Edinburgh), Vittorio Gallo (Children's National Medical Center and George Washington University), Steven Goldman (University of Rochester Medical Center), Catherine Lubetzki (Pierre and Marie Curie University), Wendy B. Macklin (University of Colorado School of Medicine), David Rowitch (University of California, San Francisco), Bruno Stankoff (Pierre and Marie Curie University)

    This translational conference will highlight biological and clinical findings in myelin development, new techniques for brain imaging and for screening molecular targets, and novel therapeutics that promote remyelination.

    Thursday, July 31, 2014 | 8:00 AM - 5:00 PM

    Fifty Years of the Genetic Code:
    A Symposium to Honor the Legacy of Marshall Nirenberg

    Speakers: C. Thomas Caskey (Baylor College of Medicine, Houston, TX, USA), Jason Chin (University of Cambridge, UK), Gregory A. Petsko (Weill Cornell Medical College, New York, NY, USA), Frank Portugal (The Catholic University of America, Washington, DC, USA), Venki Ramakrishnan (MRC Laboratory of Molecular Biology, Cambridge, UK), Jonathan Weissman (University of California - San Francisco, California, CA, USA), Lei Wang (The Salk Institute for Biological Studies, La Jolla, California, USA), Huanming Yang (BGI, Shenzhen, China)

    The identification of the genetic code has offered many opportunities in scientific, medical and biological discovery. This symposium honors Nobel Laureate Marshall Nirenberg and showcases research in a range of therapeutic areas.

    Tuesday, September 30, 2014 | 8:00 AM - 5:00 PM

    Elucidating GPCR Functional Selectivity: Novel Opportunities for Drug Development

    Keynote Speaker: Nobel Laureate Robert J. Lefkowitz (Duke University Medical Center)
    Speakers: Bryan Roth (University of North Carolina at Chapel Hill School of Medicine), Terry Kenakin (University of North Carolina at Chapel Hill School of Medicine), Marc G. Caron (Duke University Medical Center), Laura Bohn (The Scripps Research Institute), Michael Ehlers (Pfizer), JoAnn Trejo (University of California-San Diego), Jonathan Violin (Trevena, Inc.)

    Hear academic, industry, basic and translational researchers, including Nobel Laureate Robert Lefkowitz (Duke University Medical Center) and discuss the development of functionally selective GPCR-biased ligands for CV and CNS disease drug discovery.

  • Past Events

    Thursday, April 10, 2014 | 8:30 AM - 4:30 PM

    Mitochondria, Metabolism and Disease

    Speakers: Robert Balaban (National Heart, Lung, and Blood Institute, NIH), Robert Bao (Massachusetts General Hospital), Salvatore DiMauro (Columbia University Medical Center), Steven Gross (Weill Cornell Medical College), Costas A. Lyssiotis (Weill Cornell Medical College), Jared Rutter (University of Utah School of Medicine), Hazel H. Szeto (Weill Cornell Medical College), Benjamin P. Tu (UT Southwestern Medical Center)

    Damage to mitochondria, which are critical in metabolism, underlies a wide range of human diseases, making them an important therapeutic target. Researchers aim to characterize and cure diseases arising from aberrant mitochondrial metabolism.

    Tuesday, April 8, 2014 | 8:30 AM - 4:30 PM

    Translational Neuroscience in Psychiatry: Light at the End of the Tunnel

    Speakers: Dan V. Iosifescu (Icahn School of Medicine at Mount Sinai), Daniel C. Javitt (Columbia University and Nathan Kline Institute), John H. Krystal (Yale University), Andrew F. Leuchter (University of California, Los Angeles), Gregory Light (University of California, San Diego), Siva Digavalli (Bristol-Myers Squibb), Eva Redei (Northwestern University), Steven J. Siegel (University of Pennsylvania)

    Recent breakthrough insights from clinical studies are illuminating the neurobiology of psychiatric disorders. This symposium explores differences in sensory processing, imaging, and other biomarkers that may translate findings to animal models.

    March 15 - 17, 2014 | Qatar

    Qatar Clinical Neuroscience Conference

    Featuring: Huda Akil (University of Michigan), Karl Deisseroth (Stanford University)

    Join global experts in clinical neuroscience in Doha, Qatar, for a 2.5 day, two-track conference that will feature recent advances in the understanding and treatment of mood disorders, stroke, and traumatic brain injury.

    Tuesday, December 10, 2013 | 8:30 AM - 4:30 PM

    A Truce in the BAP-tist/Tau-ist War? Progress Toward A Unified Understanding of Alzheimer's Disease

    Speakers: Frank M. LaFerla (University of California, Irvine), Sylvain E. Lesné (University of Minnesota), Bingwei Lu (Stanford University School of Medicine), Lennart Mucke (Gladstone Institute of Neurological Disease), Ralph A. Nixon (Nathan Kline Institute), Franck Polleux (Columbia University), Terrence Town (University of Southern California), Tony Wyss-Coray (Stanford University School of Medicine)
    Organizers: Ken Jones (Forest Research Institute), Robert Martone (Covance Biomarker Center of Excellence), Robert B. Nelson (Lundbeck Research USA), Jennifer Henry (The New York Academy of Sciences)

    This symposium explores how efforts to better integrate our understanding of neuritic plaques and neurofibrillary tangles—the two hallmark pathologies of Alzheimer's disease—are leading to a 'truce' between former rivals in the quest for therapies.

  • Publications 

    eBriefing

    Fast-tracking Alzheimer's Research: Global Alzheimer's Platform Design Workshop

    Team Leaders: Paul Aisen (University of California, San Diego), Russell L. Barton (Eli Lilly and Company), Randall J. Bateman (Washington University), Howard Feldman (University of British Columbia, Canada), Michael T. Ropacki (Janssen Research & Development), Andrew Satlin (Eisai Inc.), Eric R. Siemers (Eli Lilly and Company), Reisa A. Sperling (Harvard Medical School), and Luc Truyen (Johnson & Johnson)

    The Global Alzheimer's Platform (GAP) aims to establish a drug discovery process to expedite AD research. This eBriefing documents a workshop convened to plan how to build the platform.

    eBriefing

    Alzheimer's Disease Summit: The Path to 2025

    Keynote Speakers: Yuko Harayama (Council for Science and Technology Policy, Cabinet Office, Japan), Richard J. Hodes (National Institute on Aging, NIH), Jan M. Lundberg (Eli Lilly and Company), and Bengt Winblad (Karolinska Institute, Sweden)

    This eBriefing outlines a research agenda crafted by leading industry, academic, and government stakeholders to advance the goals of the U.S. National Alzheimer's Plan.

    Annals

    Advances in Meditation Research: Neuroscience and Clinical Applications

    Edited by Sonia Sequeira (Memorial Sloan-Kettering Cancer Center, New York, New York)

    This Annals volume explores the ways in which meditative practice can affect consciousness, brain structure and function, aging, and clinical outcomes.

    Annals

    Annals Reports

    Edited by Annals of the New York Academy of Sciences editorial staff

    This Annals volume presents three meeting reports: (1) Probiotics, Prebiotics, and the Host Microbiome: the Science of Translation; (2) Capacity Building in Nutrition Science: Revisiting the Curricula for Medical Professionals; and (3) Circadian Clocks, Brain Function, and Development.

    Volume 1306

  • Podcasts

    Podcast
    August 27, 2010

    Better Brains

    Neuroscientist Richard Restak thinks with the right mental exercises, our brains can be much better. Today he teams with writer Susan Orlean to talk about our brainy potential.

    Download (35 MB, 00:54:21)
    Podcast
    May 14, 2010

    Why Him, Why Her?

    What attracts us to a mate? Is "chemistry" really to blame for love at first sight? Biological anthropologist Helen Fisher explains the science behind our mating preferences.

    Download (36 MB, 00:55:43)
    Podcast
    March 12, 2010

    Meditating Health

    Can meditation have long-term beneficial effects on the plasticity of our brains? Bon meditation practitioner Alejandro Chaoul and oncologist Lorenzo Cohen evaluate the healing potential of meditation in a discussion from the Rubin Museum of Art's Brainwave Festival.

    Download (28 MB, 00:43:47)
    Podcast
    February 19, 2010

    Extreme Fear

    Science journalist and adventure-seeker Jeff Wise talks about his new book Extreme Fear: The Science of Your Mind in Danger.

    Download (14 MB, 00:21:48)
  • Webinar Archives

    Webinar Archive
    February 23, 2010

    Metabotropic Glutamate Receptors: Translation from Discovery to Clinical Trials

    Researchers met to discuss advances in basic and translational research on metabotropic glutamate receptors, which are promising targets in drug discovery for CNS diseases and other illnesses.

    Webinar Archive
    October 27, 2009

    Is Alzheimer's Disease Type 3 Diabetes?

    What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? In a recent Academy webinar, some researchers argued that the neurodegenerative disease should be considered a type of diabetes.

  • Translational Medicine Initiative

    Macy FoundationThe Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.

    Learn more at www.nyas.org/TransMed.